中老年人中等至剧烈强度体力活动水平与心血管疾病的相关性

Correlation between moderate to vigorous physical activity levels and cardiovascular disease in middle-aged and elderly people

  • 摘要:
    目的 探究中等至剧烈强度体力活动水平(MVPA)与心血管疾病(CVD)相关性,为CVD的预防和控制提供依据。
    方法 本研究的数据来自2015年和2020年的中国健康与养老追踪调查(CHARLS)。纳入6 100例具有体力活动和心血管状态数据的中老年人群。采用逻辑回归模型探讨MVPA与CVD的关系,并且针对年龄和性别进行亚组分析。
    结果 患有CVD人群的MVPA显著低于健康人群(5 040 MET min/周vs 6 160 MET min/周,P<0.001)。在校正混杂因素后,MVPA每上升一个四分位数,CVD的患病风险降低13.2%(OR=0.868,95%CI:0.765~0.985),且MVPA与新发CVD风险之间存在非线性剂量反应联系(P总体<0.05,P非线性<0.10), 新发CVD风险的拐点为5 674.47 MET min/周。将MVPA按四分位数进行计算,与MVPA的第一四分位数(Q1)相比,第三四分位数(Q3)和第四四分位数(Q4)与新发CVD风险降低相关(OR=0.76,95%CI=0.63~0.92;OR=0.81,95%CI=0.66~0.98)。心脏病的结果与CVD类似,与MVPA的第一四分位数(Q1)相比,第三四分位数(Q3)的新发心脏病风险降低22%(OR=0.78,95%CI=0.63~0.95)。
    结论 MVPA可能是CVD/心脏病的保护因素,并且在女性和老年人群中这种相关性可能受益更多。

     

    Abstract:
    Objective To investigate the correlation between moderate to vigorous physical activity (MVPA) levels and cardiovascular disease (CVD), so as to provide a basis for the prevention and control of CVD.
    Methods Data for this study were obtained from the China Health and Retirement Longitudinal Study (CHARLS) in 2015 and 2020. A cohort of 6, 100 middle-aged and elderly people with data on physical activity and cardiovascular status was included. Logistic regression modeling was used to explore the association between MVPA and CVD, and subgroup analyses were conducted for age and gender.
    Results The amount of MVPA in the population with CVD was significantly lower than that in the normal population (5, 040 MET min/week vs 6, 160 MET min/week, P < 0.001). After adjusting for confounding factors, for every one quartile increase in MVPA, the risk of developing CVD was decreased by 13.2% (OR=0.868, 95% CI: 0.765-0.985). Moreover, there was a non-linear dose- response relationship between MVPA and the risk of new-onset CVD (Poverall < 0.05, Pnonlinearity < 0.10), and the inflection point for the risk of new-onset CVD was 5, 674.47 MET min/week. When MVPA was calculated according to quartile, compared with the first quartile (Q1) of MVPA, the third quartile (Q3) and fourth quartile (Q4) were associated with a reduced risk of new-onset CVD (OR=0.76, 95% CI=0.63-0.92; OR=0.81, 95% CI=0.66-0.98). The outcomes of heart diseases were similar to those of CVD. The risk of new-onset heart diseases in Q3 of MVPA was reduced by 22% compared with that in Q4 (OR=0.78, 95% CI=0.63-0.95).
    Conclusion MVPA may be a protective factor for CVD/heart disease, and this association may benefit more in women and older populations.

     

/

返回文章
返回